Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 26 Jul 2022

Paeoniflorin Inhibits EMT and Angiogenesis in Human Glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent Autophagic Degradation

in Pharmacology of Anti-Cancer Drugs

Zhi Liu
Zhaotao Wang
Danmin Chen
Xiaorui Liu
Guoyong Yu
Yan Zhang
Chen Chen
Ruxiang Xu
Yezhong Wang
Ru-en Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.785345

3,288 views
12 citations

Editorial

Published on 26 Jul 2022

Editorial: New insights into the mechanisms of resistance to anti-cancer drugs

in Pharmacology of Anti-Cancer Drugs

Francesco Bertoni
Simona Rapposelli

Frontiers in Oncology

doi 10.3389/fonc.2022.990144

1,317 views

Original Research

Published on 22 Jul 2022

CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells

in Pharmacology of Anti-Cancer Drugs

Graziana Digiacomo
Claudia Fumarola
Silvia La Monica
Mara Bonelli
Andrea Cavazzoni
Maricla Galetti
Rita Terenziani
Kamal Eltayeb
Francesco Volta
Silvia Zoppi

Frontiers in Oncology

doi 10.3389/fonc.2022.942341

5,187 views
17 citations

Original Research

Published on 22 Jul 2022

A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Sarfraz Ahmed
Mohammad Mobashir
Lamya Ahmed Al-Keridis
Nawaf Alshammari
Mohd Adnan
Mohammad Abid
Md Imtaiyaz Hassan

Frontiers in Oncology

doi 10.3389/fonc.2022.914032

4,388 views
19 citations

Original Research

Published on 22 Jul 2022

Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma Cells

in Pharmacology of Anti-Cancer Drugs

Tingze Feng
Tianzhi Wu
Yanxia Zhang
Lang Zhou
Shanshan Liu
Lin Li
Ming Li
Erqiang Hu
Qianwen Wang
Xiaocong Fu

Frontiers in Oncology

doi 10.3389/fonc.2022.912694

4,631 views
8 citations

Original Research

Published on 15 Jul 2022

Effects of glycolysis and polyamine predation on intestinal epithelial barrier in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Yu Wang
Huan He
Jingwen Chen
Zijing Song
Xuediao Pan
Tian Lan
Guixiang Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.961257

2,576 views
5 citations

Review

Published on 15 Jul 2022

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Haoming Xia
Ziyue Huang
Zhensheng Wang
Shuqiang Liu
Xudong Zhao
Junqi You
Yi Xu
Judy Wai Ping Yam
Yunfu Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.953668

3,580 views
10 citations

Original Research

Published on 14 Jul 2022

Glaucocalyxin A Inhibits the Malignant Progression of Epithelial Ovarian Cancer by Affecting the MicroRNA-374b-5p/HMGB3/Wnt-β-Catenin Pathway Axis

in Pharmacology of Anti-Cancer Drugs

Feng Chen
Fang Sun
Xia Liu
Jing Shao
Bei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.955830

2,236 views
3 citations

Mini Review

Published on 14 Jul 2022

Current Progress in Cancer Treatment Using Nanomaterials

in Pharmacology of Anti-Cancer Drugs

Ruirui Zhu
Fangyuan Zhang
Yudong Peng
Tian Xie
Yi Wang
Yin Lan

Frontiers in Oncology

doi 10.3389/fonc.2022.930125

14,115 views
56 citations

Original Research

Published on 14 Jul 2022

SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis

in Pharmacology of Anti-Cancer Drugs

Meng Cheng
Qingmiao Yang
Yafei Liu
Meng-Jie Zhao
Xinyuan Du
Jiaqi Sun
Wen-Jie Shu
Zan Huang
Jianping Bi
Ximing Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.882202

4,448 views
4 citations

Systematic Review

Published on 13 Jul 2022

Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer

in Pharmacology of Anti-Cancer Drugs

Tomi Lois Adetunji
Femi Olawale
Chijioke Olisah
Ademola Emmanuel Adetunji
Adeyemi Oladapo Aremu

Frontiers in Oncology

doi 10.3389/fonc.2022.908487

20,579 views
46 citations

Original Research

Published on 13 Jul 2022

Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment

in Pharmacology of Anti-Cancer Drugs

Rosaria Chilà
Michela Chiappa
Federica Guffanti
Nicolò Panini
Donatella Conconi
Andrea Rinaldi
Luciano Cascione
Francesco Bertoni
Maddalena Fratelli
Giovanna Damia

Frontiers in Oncology

doi 10.3389/fonc.2022.903536

5,524 views
5 citations

Original Research

Published on 13 Jul 2022

Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer

in Pharmacology of Anti-Cancer Drugs

Liankun Song
Merci Mino
Jana Yamak
Vyvyan Nguyen
Derron Lopez
Victor Pham
Ali Fazelpour
Vinh Le
Dongjun Fu
Matthew Tippin

Frontiers in Oncology

doi 10.3389/fonc.2022.943846

5,448 views
10 citations

Original Research

Published on 13 Jul 2022

Endoscopic or Follow-up Treatment for Gastric Indeterminate Tumors Is the Preferred Method of Management

in Pharmacology of Anti-Cancer Drugs

Jun Xiao
Chao Yu
Jing Chen
Renhu Sun
Hailin Jin
Chunyang Liu
Yaohui Wang
Zhiguang Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.947810

1,752 views

Original Research

Published on 12 Jul 2022

DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis

in Pharmacology of Anti-Cancer Drugs

Shu Wang
Yuting Wu
Mingyue Liu
Qingchun Zhao
Lingyan Jian

Frontiers in Oncology

doi 10.3389/fonc.2022.955729

2,359 views
4 citations

Original Research

Published on 12 Jul 2022

The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients

in Pharmacology of Anti-Cancer Drugs

Da-li Zhang
Dan-ni Feng
Xi He
Xiao-feng Zhang
Li-xin Li
Zhi-jie Li
Xiao-feng Niu
Yun-long Zhuang
Zhen-wen Liu
Xu-dong Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.959151

4,779 views
3 citations